Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of obstructive voiding dysfunction.

R Mark Ellerkmann1, Andrew McBride

  • 1Johns Hopkins Medicine, Division of Urogynecology and Reconstructive Pelvic Surgery, Greater Baltimore Medical Center, Baltimore, Maryland 21204, USA.

Drugs of Today (Barcelona, Spain : 1998)
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyrocarbon shoulder hemiarthroplasty: A surgical technique.

Shoulder & elbow·2026
Same author

PyroTITAN Pyrocarbon Shoulder Hemiarthroplasty: Clinical and Radiographic Outcomes with Medium-Term Follow-up.

The Journal of bone and joint surgery. American volume·2026
Same author

Faculty-student differences in authorship perceptions before and after authorship ethics interventions.

Accountability in research·2026
Same author

Investigating the replicability of the social and behavioural sciences.

Nature·2026
Same author

Outcomes of pyrolytic carbon humeral resurfacing hemiarthroplasty compared to best-in-class total shoulder arthroplasty in young patients with osteoarthritis: analysis from the Australian Orthopaedic Association National Joint Replacement Registry.

Journal of shoulder and elbow surgery·2025
Same author

Intervention to Promote Ethical Authorship Practices in Graduate Education.

Science and engineering ethics·2025
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Voiding dysfunction, difficulty emptying the bladder, has gender-specific causes and treatments. This review covers various therapies for men and women to resolve symptoms without causing new issues.

Area of Science:

  • Urology
  • Medical Science

Background:

  • Voiding dysfunction involves impaired bladder emptying, ranging from minor irritative symptoms to complete retention.
  • Effective management requires accurate diagnosis of underlying pathology to restore bladder function and anatomy.

Purpose of the Study:

  • To review the gender-specific causes and diverse treatments for obstructive voiding dysfunction in men and women.
  • To provide an overview of current and emerging therapeutic options for resolving bladder emptying symptoms.

Main Methods:

  • Literature review of causes and treatments for obstructive voiding dysfunction.
  • Analysis of gender-specific etiologies, including pelvic organ prolapse and benign prostate disease.
  • Synthesis of pharmacological and operative treatment strategies.

Related Experiment Videos

Main Results:

  • In women, prior anti-incontinence surgery and pelvic organ prolapse are common causes, often requiring surgical intervention.
  • Benign prostate disease is the predominant cause in aging men, with numerous pharmacological and surgical treatments available.
  • A wide array of treatments exist for various causes of obstructive voiding dysfunction.

Conclusions:

  • Accurate diagnosis and targeted therapy are crucial for resolving voiding dysfunction symptoms.
  • Treatment strategies aim to restore bladder function and anatomy without inducing new pathologies.
  • The review highlights the importance of addressing gender-specific causes for effective voiding dysfunction management.